Find Flavoxate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

171RELATED EXCIPIENT COMPANIES

263EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

GLOBAL SALES INFORMATION

Annual Reports

NA

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 3717-88-2, Flavoxate hcl, Urispas, Dw-61, Flavoxate (hydrochloride), Bladderon
Molecular Formula
C24H26ClNO4
Molecular Weight
427.9  g/mol
InChI Key
XOEVKNFZUQEERE-UHFFFAOYSA-N
FDA UNII
9C05J6089W

Flavoxate
A drug that has been used in various urinary syndromes and as an antispasmodic. Its therapeutic usefulness and its mechanism of action are not clear. It may have local anesthetic activity and direct relaxing effects on smooth muscle as well as some activity as a muscarinic antagonist.
1 2D Structure

Flavoxate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-piperidin-1-ylethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate;hydrochloride
2.1.2 InChI
InChI=1S/C24H25NO4.ClH/c1-17-21(26)19-11-8-12-20(23(19)29-22(17)18-9-4-2-5-10-18)24(27)28-16-15-25-13-6-3-7-14-25;/h2,4-5,8-12H,3,6-7,13-16H2,1H3;1H
2.1.3 InChI Key
XOEVKNFZUQEERE-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=C(OC2=C(C1=O)C=CC=C2C(=O)OCCN3CCCCC3)C4=CC=CC=C4.Cl
2.2 Other Identifiers
2.2.1 UNII
9C05J6089W
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Bladuril

2. Flavoxate

3. Hydrochloride, Flavoxate

4. Spasuret

5. Urispas

6. Uronid

2.3.2 Depositor-Supplied Synonyms

1. 3717-88-2

2. Flavoxate Hcl

3. Urispas

4. Dw-61

5. Flavoxate (hydrochloride)

6. Bladderon

7. Peflate

8. Spasmal

9. Nsc-114649

10. Dw 61 (flavoxate)

11. 2-(piperidin-1-yl)ethyl 3-methyl-4-oxo-2-phenyl-4h-chromene-8-carboxylate Hydrochloride

12. Rec 7/0040

13. Rec-7-0040;dw61

14. Flavoxate Hydrochloride

15. Chebi:5089

16. 2-piperidinoethyl 3-methyl-4-oxo-2-phenyl-4h-1-benzopyran-8-carboxylate Hydrochloride

17. 9c05j6089w

18. Piperidinoethyl-3-methylflavone-8-carboxylate Hydrochloride

19. Spasuret Hydrochloride

20. Dsstox_cid_27764

21. Dsstox_rid_82541

22. Dsstox_gsid_47784

23. 4h-1-benzopyran-8-carboxylic Acid, 3-methyl-4-oxo-2-phenyl-, 2-(1-piperidinyl)ethyl Ester, Hydrochloride

24. Genurin

25. Spasuret

26. Urispadol

27. Verrispasmin Amp.

28. 2-piperidin-1-ylethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate;hydrochloride

29. Ak 123

30. Nsc114649

31. Rec-7-0040

32. Ncgc00016636-01

33. Cas-3717-88-2

34. Ccris 1950

35. Sr-01000872667

36. Unii-9c05j6089w

37. Prestwick_884

38. Einecs 223-066-4

39. Mfcd00072099

40. Nsc 114649

41. Rec 7-0040

42. Flavoxate Hydrochloride [usan:usp:jan]

43. Rec-7-0040 Hcl

44. Mls002154247

45. Schembl124540

46. Dw61

47. Chembl1200875

48. Dtxsid1047784

49. Hy-b0549a

50. 1-piperidinoethanol, Hydrochloride

51. Hms1568b06

52. Bcp13298

53. Flavoxate Hydrochloride [mi]

54. Tox21_110537

55. Flavoxate Hydrochloride (jp17/usp)

56. Flavoxate Hydrochloride [jan]

57. S4027

58. Flavoxate Hydrochloride [usan]

59. Akos025310107

60. Tox21_110537_1

61. Ac-1093

62. Ccg-220242

63. Flavoxate Hydrochloride [mart.]

64. 1-piperidineethanol, 3-methyl-4-oxo-2-phenyl-4h-1-benzopyran-8-carboxylate, Hydrochloride

65. 2-piperidin-1-ylethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate Hydrochloride

66. Flavoxate Hydrochloride [usp-rs]

67. Flavoxate Hydrochloride [who-dd]

68. Dw-61;rec-7-0040;dw61

69. Ncgc00016636-05

70. 4h-1-benzopyran-8-carboxylic Acid, 3-methyl-4-oxo-2-phenyl-, 2-piperidinoethyl Ester, Hydrochloride

71. As-12321

72. Smr000499576

73. F0717

74. Flavoxate Hydrochloride [ep Impurity]

75. Flavoxate Hydrochloride [orange Book]

76. Ft-0658191

77. Ft-0668549

78. Sw197005-3

79. Flavoxate Hydrochloride [ep Monograph]

80. D00718

81. D90684

82. Flavoxate Hydrochloride [usp Monograph]

83. Flavoxate Hydrochloride, >=98% (hplc), Solid

84. J-521367

85. Sr-01000872667-1

86. Q27106648

87. Wln: T66 Bo Evj Cr& D1 Jvo2- At6ntj &gh

88. 4h-1-benzopyran-8-carboxylic Acid, 2-piperidinoethyl Ester, Hydrochloride

89. Flavoxate Hydrochloride, European Pharmacopoeia (ep) Reference Standard

90. Flavoxate Hydrochloride, United States Pharmacopeia (usp) Reference Standard

91. 1-(2-{[(3-methyl-4-oxo-2-phenyl-4h-chromen-8-yl)carbonyl]oxy}ethyl)piperidinium Chloride

92. 2-(piperidin-1-yl)ethyl3-methyl-4-oxo-2-phenyl-4h-chromene-8-carboxylatehydrochloride

93. 2-piperidinoethyl-3-methyl-4-oxo-2-phenyl-4h-1-benzopyran-8-carboxylate Hydrochloride

94. 4h-1-benzopyran-8-carboxylic Acid, 2-(1-piperidinyl)ethyl Ester, Hydrochloride

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 427.9 g/mol
Molecular Formula C24H26ClNO4
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count5
Rotatable Bond Count6
Exact Mass427.1550360 g/mol
Monoisotopic Mass427.1550360 g/mol
Topological Polar Surface Area55.8 Ų
Heavy Atom Count30
Formal Charge0
Complexity631
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameFlavoxate hydrochloride
Drug LabelFlavoxate hydrochloride tablets contain flavoxate hydrochloride, a synthetic urinary tract spasmolytic.Chemically, flavoxate hydrochloride is 2-piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate hydrochloride. The empirical formula...
Active IngredientFlavoxate hydrochloride
Dosage FormTablet
RouteOral
Strength100mg
Market StatusPrescription
CompanyImpax Pharms; Epic Pharma; Paddock

2 of 2  
Drug NameFlavoxate hydrochloride
Drug LabelFlavoxate hydrochloride tablets contain flavoxate hydrochloride, a synthetic urinary tract spasmolytic.Chemically, flavoxate hydrochloride is 2-piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate hydrochloride. The empirical formula...
Active IngredientFlavoxate hydrochloride
Dosage FormTablet
RouteOral
Strength100mg
Market StatusPrescription
CompanyImpax Pharms; Epic Pharma; Paddock

5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Parasympatholytics

Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)


Urological Agents

Drugs used in the treatment of urological conditions and diseases such as URINARY INCONTINENCE and URINARY TRACT INFECTIONS. (See all compounds classified as Urological Agents.)


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
Cholinergic Muscarinic Antagonists [MoA]; Cholinergic Muscarinic Antagonist [EPC]

Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothJai Radhe Sales is your partner for all your sourcing needs.

Flag India
Digital Content Digital Content

Flavoxate

About the Company : Jai Radhe Sales, founded in 1999, is a global distributor specializing in high-quality pharmaceutical ingredients from India. It offers complete sourcing solutions, technical and r...

Jai Radhe Sales, founded in 1999, is a global distributor specializing in high-quality pharmaceutical ingredients from India. It offers complete sourcing solutions, technical and regulatory support, and strives for global standards. Known for quality and affordability, it has established a niche through innovative methods and exports to nearly every continent. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Jai Radhe Sales

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAMI Lifesciences is Driven by Chemistry. Powered by People.

Flag India
Digital Content Digital Content

Flavoxate Hydrochloride

About the Company : Ami Lifesciences, established in 2006, is a rapidly growing API manufacturing company in India with strong capabilities in cardiovascular, anti-diabetic, CNS, and respiratory thera...

Ami Lifesciences, established in 2006, is a rapidly growing API manufacturing company in India with strong capabilities in cardiovascular, anti-diabetic, CNS, and respiratory therapies. The company offers a diverse portfolio of APIs, intermediates, key starting materials, and contract bulk manufacturing services. Its advanced manufacturing facilities in Gujarat and Karnataka feature dedicated clean rooms and comply with EU-GMP, WHO-GMP, PMDA, and COFEPRIS standards. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
AMI Lifesciences

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBioXera Pharma: A trusted partner for high-quality human and veterinary APIs and intermediates across global regulated markets.

Flag India
Digital Content Digital Content

Flavoxate

About the Company : BioXera Pharma is a quality-focused manufacturer of APIs, veterinary APIs, and intermediates, with expertise in innovative process development for domestic and regulated internatio...

BioXera Pharma is a quality-focused manufacturer of APIs, veterinary APIs, and intermediates, with expertise in innovative process development for domestic and regulated international markets. The company operates a modern manufacturing facility in Ambernath, Maharashtra which has regulatory approvals like EU GMP, WHO GMP and has been audited by KFDA. Its flexible infrastructure supports development from laboratory scale to commercial production, enabling an expanding portfolio and pipeline. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Bioxera CB

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSymbiotica delivers high-quality APIs through advanced R&D, GMP-certified manufacturing, & trusted global pharmaceutical partnerships.

Flag Malaysia
Digital Content Digital Content

Flavoxate Hydrochloride

About the Company : Symbiotica is a Malaysia-based manufacturer of high-quality Active Pharmaceutical Ingredients (APIs), specialising in steroidal, hormonal, and niche non-steroidal compounds for glo...

Symbiotica is a Malaysia-based manufacturer of high-quality Active Pharmaceutical Ingredients (APIs), specialising in steroidal, hormonal, and niche non-steroidal compounds for global pharmaceutical markets. With over 25 years of industry expertise, we serve 250+ clients across 80+ countries through PIC/S GMP, USFDA, PMDA certified facilities. Our tailored API solutions are driven by strong R&D, stringent quality systems, and regulatory compliance, delivering reliable and innovative pharmaceutical solutions worldwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Company Banner

05

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Flavoxate

About the Company : Amuna Pharmaceuticals is an emerging contract research and manufacturing organization (CRMO) that caters to the needs of small, mid-size, and large pharmaceutical and biotechnology...

Amuna Pharmaceuticals is an emerging contract research and manufacturing organization (CRMO) that caters to the needs of small, mid-size, and large pharmaceutical and biotechnology companies engaged in New Chemical Entity (NCE) drug discovery. Headquartered in New Jersey, Amuna Pharma operates its research and development center in Ahmedabad, India, offering a full range of services. These services include synthetic chemistry, medicinal chemistry, and custom synthesis across a range of scales from milligrams to kilograms.
blank

06

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Flavoxate

About the Company : Aspire group was established in the year 2000 with a motto of quality drug for better health of all. In its journey till date, aspire has developed enormous reputation, consistent ...

Aspire group was established in the year 2000 with a motto of quality drug for better health of all. In its journey till date, aspire has developed enormous reputation, consistent growth, unique technologies and world class quality healthcare products. Aspire is pioneer in manufacturing and sourcing unique healthcare products. True to the statement, “Where the future started yesterday” with a foresight on the current trends in the healthcare market, Aspire has grown from strength combining its research strength, Human resources and well established quality systems. Aspire has crossed numerous milestones in a comparatively short period since its inception.
blank

07

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Flavoxate HCl

About the Company : Delta Finochem Pvt Ltd. is a privately owned and professionally managed company, accredited by WHO-GMP & ISO 9001:2015 (Year of establishment 1994) Delta Finochem is a leading manu...

Delta Finochem Pvt Ltd. is a privately owned and professionally managed company, accredited by WHO-GMP & ISO 9001:2015 (Year of establishment 1994) Delta Finochem is a leading manufacturers of Active Pharmaceutical Ingredients (Generics), Drug Intermediates, Quaternary Ammonium Compounds, Quaternary Phosphonium compounds. Our focus is on niche products, with a presence in several countries. Our partners are essentially innovators and generic drug companies across the globe for whom we develop a range of new niche products.
blank

08

Ocimum Labs

India
PEGS Boston Summit
Not Confirmed
arrow

Ocimum Labs

India
arrow
PEGS Boston Summit
Not Confirmed

Flavoxate

About the Company : Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular...

Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
blank

09

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Flavoxate

About the Company : Souvin Pharmaceuticals (I)Pvt.Ltd. based in Pune, is an integrated and active Pharmaceutical ingredients (A.P.I s) and intermediates manufacturing company. The Company is managed b...

Souvin Pharmaceuticals (I)Pvt.Ltd. based in Pune, is an integrated and active Pharmaceutical ingredients (A.P.I s) and intermediates manufacturing company. The Company is managed by professionals who have more than 25 years of experience from Pharmaceutical industry. The technical expertise, organizational strength, and infrastructure have been instrumental in the growth of this organization. The company started its operations in the year 2010. Though a new entrant, the organization is confident to achieve a turnover of at least Rs. 100 crores in the next five years.
blank

10

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Flavoxate

About the Company : Zeal Medipharma is a Star-rated Export House serving customers in over 50 countries for more than two decades. The company specializes in sourcing and exporting APIs for human and ...

Zeal Medipharma is a Star-rated Export House serving customers in over 50 countries for more than two decades. The company specializes in sourcing and exporting APIs for human and veterinary use, along with drug intermediates, excipients, and semi-finished forms such as pellets and DC granules. Its portfolio also includes herbal extracts, phytochemicals, nutraceuticals, food and feed ingredients, agrochemicals, preservatives, surfactants, and specialty chemicals, supporting global healthcare and industrial markets. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Coating Systems & Additives

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Controlled & Modified Release

read-more
read-more

Direct Compression

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Granulation

read-more
read-more

Topical

read-more
read-more

Lubricants & Glidants

read-more
read-more

Co-Processed Excipients

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Solubilizers

read-more
read-more

Taste Masking

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Empty Capsules

read-more
read-more

API Stability Enhancers

read-more
read-more

Emulsifying Agents

read-more
read-more

Vegetarian Capsules

read-more
read-more

Parenteral

read-more
read-more

Rheology Modifiers

read-more
read-more

Coloring Agents

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 3717-88-2 / Flavoxate API manufacturers, exporters & distributors?

Flavoxate manufacturers, exporters & distributors 1

53

PharmaCompass offers a list of Flavoxate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Flavoxate manufacturer or Flavoxate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Flavoxate manufacturer or Flavoxate supplier.

API | Excipient name

Flavoxate

Synonyms

3717-88-2, Flavoxate hcl, Urispas, Dw-61, Flavoxate (hydrochloride), Bladderon

Cas Number

3717-88-2

Unique Ingredient Identifier (UNII)

9C05J6089W

About Flavoxate

A drug that has been used in various urinary syndromes and as an antispasmodic. Its therapeutic usefulness and its mechanism of action are not clear. It may have local anesthetic activity and direct relaxing effects on smooth muscle as well as some activity as a muscarinic antagonist.

Flavoxate HCl Manufacturers

A Flavoxate HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Flavoxate HCl, including repackagers and relabelers. The FDA regulates Flavoxate HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Flavoxate HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Flavoxate HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Flavoxate HCl Suppliers

A Flavoxate HCl supplier is an individual or a company that provides Flavoxate HCl active pharmaceutical ingredient (API) or Flavoxate HCl finished formulations upon request. The Flavoxate HCl suppliers may include Flavoxate HCl API manufacturers, exporters, distributors and traders.

click here to find a list of Flavoxate HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Flavoxate HCl USDMF

A Flavoxate HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of Flavoxate HCl active pharmaceutical ingredient (API) in detail. Different forms of Flavoxate HCl DMFs exist exist since differing nations have different regulations, such as Flavoxate HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Flavoxate HCl DMF submitted to regulatory agencies in the US is known as a USDMF. Flavoxate HCl USDMF includes data on Flavoxate HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Flavoxate HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Flavoxate HCl suppliers with USDMF on PharmaCompass.

Flavoxate HCl JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Flavoxate HCl Drug Master File in Japan (Flavoxate HCl JDMF) empowers Flavoxate HCl API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Flavoxate HCl JDMF during the approval evaluation for pharmaceutical products. At the time of Flavoxate HCl JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Flavoxate HCl suppliers with JDMF on PharmaCompass.

Flavoxate HCl KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Flavoxate HCl Drug Master File in Korea (Flavoxate HCl KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Flavoxate HCl. The MFDS reviews the Flavoxate HCl KDMF as part of the drug registration process and uses the information provided in the Flavoxate HCl KDMF to evaluate the safety and efficacy of the drug.

After submitting a Flavoxate HCl KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Flavoxate HCl API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Flavoxate HCl suppliers with KDMF on PharmaCompass.

Flavoxate HCl WC

A Flavoxate HCl written confirmation (Flavoxate HCl WC) is an official document issued by a regulatory agency to a Flavoxate HCl manufacturer, verifying that the manufacturing facility of a Flavoxate HCl active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Flavoxate HCl APIs or Flavoxate HCl finished pharmaceutical products to another nation, regulatory agencies frequently require a Flavoxate HCl WC (written confirmation) as part of the regulatory process.

click here to find a list of Flavoxate HCl suppliers with Written Confirmation (WC) on PharmaCompass.

Flavoxate HCl NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Flavoxate HCl as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Flavoxate HCl API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Flavoxate HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Flavoxate HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Flavoxate HCl NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Flavoxate HCl suppliers with NDC on PharmaCompass.

Flavoxate HCl GMP

Flavoxate HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Flavoxate HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Flavoxate HCl GMP manufacturer or Flavoxate HCl GMP API supplier for your needs.

Flavoxate HCl CoA

A Flavoxate HCl CoA (Certificate of Analysis) is a formal document that attests to Flavoxate HCl's compliance with Flavoxate HCl specifications and serves as a tool for batch-level quality control.

Flavoxate HCl CoA mostly includes findings from lab analyses of a specific batch. For each Flavoxate HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Flavoxate HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Flavoxate HCl EP), Flavoxate HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Flavoxate HCl USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty